AI in drug discovery

News

Basecamp lifts veil on Trillion Gene Atlas genomics push

Basecamp Research's Trillion Gene Atlas will bring together genomic data from millions of species to guide AI-powered design of new medicines.

News

Roche's AI-powered digital pathology open environment in action

Roche accelerates AI adoption with NVIDIA deal

Roche has ramped up its investment in NVIDIA's AI chips, launching a hybrid-cloud AI factory that it believes is the largest in the pharma industry.

News

NVIDIA sinks $2bn into AI cloud provider Nebius

NVIDIA has agreed a $2 billion partnership with AI cloud provider Nebius to ramp up infrastructure as demand soars in the life sciences.

News

Welsh firm Antiverse raises funds for AI antibody platform

Cardiff's Antiverse has raised $9.3m to develop its AI-based design platform for antibodies against hard-to-reach targets like GPCRs and ion channels.

Digital

Legacy data into living scientific memory

The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now it’s possible to connect your data and tool ecosystem

News

MSD and Mayo Clinic team up on AI drug discovery

MSD has signed an industry-first deal with the Mayo Clinic that will allow it to use the health system's genomic and clinical data for drug discovery.

Basecamp lifts veil on Trillion Gene Atlas genomics push

Roche accelerates AI adoption with NVIDIA deal

NVIDIA sinks $2bn into AI cloud provider Nebius

Welsh firm Antiverse raises funds for AI antibody platform

Legacy data into living scientific memory

MSD and Mayo Clinic team up on AI drug discovery

Hernexeos and what’s next, with Vicky Brown

Using AI-driven synthetic personas to take your insights fur...

AI in drug discovery

Editor's Picks